Contact Us

Service Line:+1-315-239-3085

Address:FL-4, Building A5, International Enterprise Community, Tianjin, China

Email:info@kmdbioscience.com

Online Inquery

  •   
  •   
  •   
  • Refresh

Anti-Human FLT1 Recombinant Antibody

Product Information
Catalog Number YR1244
Product Name Anti-Human FLT1 Recombinant Antibody
Molecular Name Icrucumab
Alias Anti-FLT1 Recombinant Antibody, Research Grade Icrucumab
CAS Number 1024603-92-6
Target FLT1[Homo sapiens]
Isotype IgG1 Kappa
Clonity Monoclonal
Source CHO Cells
Size 1mg, 5mg
Concentration 1mg/ml
Purity >95% as determined by SDS-PAGE
Applications Neut, ELISA, IF, IP, FuncS, FCM, ICC
Buffer PBS, pH7.5
Background Icrucumab (IMC-18F1) is a human monoclonal antibody designed for the treatment of solid tumors. Icrucumab was developed by ImClone Systems Inc. It is undergoing Phase I trials.
Storage It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note This product is for research use only.